A Guide to U.S. Legislative & Regulatory Changes

Analyzing federal government developments

Overview

Businesses and entities with interests before the federal government should always be monitoring Washington, D.C., to manage risk and identify opportunities. As the Trump administration and the incoming 116th U.S. Congress make decisions that shape federal policy, Faegre Drinker's lawyers and our colleagues at Faegre Drinker Consulting are committed to helping clients understand and proactively manage the legislative and regulatory changes that impact their businesses.

In this space, Faegre Drinker consultants and lawyers will share timely insights and industry-focused resources to help companies stay ahead of the curve on issues related to federal government activity.

Insights

Updates October 2020

A Guide to U.S. Legislative & Regulatory Changes

Analyzing federal government developments

Overview

Insights

An Early Look at 2021 Medicare Advantage Benefits: Part I

Key Takeaways for Indian Country From the Coronavirus Relief Package

2020 Vision: New Information on 2020 Medicare Advantage Benefits, Part II

Congress Sends $8.3B Coronavirus Package to the President — What Does That Mean for You?

Colorado Employers: Prepare Now for Extensive New Overtime and Minimum Pay Standards

White House Releases Long-Awaited NEPA Streamlining

Tax Extenders Deal Retroactively Includes Key Biofuels Credit, Drops Others

How Will FDA Assembling the Botanical Safety Consortium Affect Your Company’s Botanical Ingredients?

Hashtag Ad: FTC Releases Disclosure Guidelines for Social Media Influencers

Standardize This: Senators Ask Feds for Clarity on Standard Essential Patent Licensing Policy

Federal Contractors: Review the 2019 Supplemental Corporate Scheduling Announcement List to See if an Audit Is Coming

Small Refinery Exemptions Fight Makes Way to Congress

Congress, Candidates and the White House Agree: Telehealth Is Policy to Get Behind

2020 Vision: Medicare Advantage Benefits for the Coming Year, Part I

DOJ Criminal Division Releases Criteria for Evaluating Companies’ Ability to Pay Fines

Biofuel Quarrel Continues Despite Trump Attempt as Peacemaker

Congress Considers Restricting Credit Checks During Hiring

Two-Year Federal Budget Deal Opens Doors for New Funding Opportunities

2 Lessons for CBD Industry in Recent FDA Warning Letter

DOJ to Reward Good Behavior With Change to Compliance Policy

5th Circuit Hears Oral Arguments in Appeal of District Court Ruling on Affordable Care Act

EPA Releases Proposed Volume Standards for Renewable Fuel Standard

Disclosure, Cooperation and Remedial Action Necessary for Credit in False Claims Act Matters, DOJ Says

The Pronounced Importance of an Unpronounceable Acronym: New Guidance on SSBCI in Medicare Advantage

CMS Announces Primary Cares Initiative: New Direction or New Messaging?

SEC Simplifies, Modernizes Reporting Requirements for Public Companies

Federal Contractors: Review the Electronic 2019 Corporate Scheduling Announcement List to See if an Audit Is Coming

Guidance on EEO-1 Component 2 Pay Data Anticipated by April 3

Common Goals & Divided Government: Highlights From the 2019 NFI Insurance Public Policy Summit

The 2018 EEO-1 Survey Is Open – But Only For Component 1 Data

Congress Shines Light on PFAS Risks

Employers: Proposed Rule Change Could Make Over a Million Workers Eligible for Overtime

Federal Court Reinstates Controversial Pay Data Collection Portion of EEO-1

Health Insurers Win Important Ruling on Payment of ACA Cost-Sharing Reductions (CSR)

Some Patents Could Be Entitled to Later Expiration Dates Than Previously Thought

Federal Contractors: Monitor the OFCCP's FOIA Library for Advance Notice of Coming Audits

The Federal Government Enters the Big Data Fray

EPA Releases Comprehensive Action Plan for Regulating PFAS Chemicals

USCIS Announces New Form I-539 With Biometrics Requirement Coming March 11, 2019

Additional Time Granted for EEO-1 Survey Filings

NLRB Revises Approach to the Age-Old Question: Employee or Independent Contractor?

Medicare Advantage Plan Adoption of New Flex Benefits in 2019

Cracking Down on Opioid Opportunists

Employers: Keep FCRA in Mind When Drafting Arbitration Agreements

Congress Fails to Enact First-Ever Significant Federal Legislation on Autonomous Vehicles

USDA Releases Long-Awaited Food Labeling Requirements for GMO Products

Federal Trial Court Strikes Down Entire Affordable Care Act

Department of Education Proposes Major Regulatory Changes for Handling Campus Sexual Misconduct

EPA Caps Busy Week for Biofuels With Release of Renewable Volume Obligations

New Guidance From DOJ Clarifies that Corporate Monitor Selection Process Begins With the Company

Patient Perspectives—There’s an App for That!

New FTC Guidance Will Require HSR Filings for More Nonprofit Hospital Affiliations/Combinations

The Election’s Impact on Health Care Interests

Is Your Investment Eligible for Opportunity Zone Funding?

Biologic and Biosimilar Settlement Agreements Now Must Be Disclosed to DOJ and FTC

Trick or Treat? Expected and Surprising Provisions in the New Medicare Advantage Regulation

For Latest Drug Pricing Proposal, It’s Back to the Future

Regulation-Slashing Trump Administration Updates Target List

What Questions Should You Be Asking About the Opportunity Zones Program?

Five New Directives From the OFCCP for Federal Contractors

CMS Greenlights Indication-Based Formulary Design: What Do You Need to Know?

EPA Lays Down ACE: What’s in the Trump Administration’s Clean Energy Rule?

Continued Enforcement by USCIS: Recent Memos on Immediate Denials and Possible Deportation for Beneficiaries of Employment-Based Immigration Petitions

2015 Waters of the United States Rule Reinstatement Leaves Industry Operating Under Patchwork of Regulations

‘Text Me Your Symptoms’: CMS Proposes Expanding Coverage for Digital Health Services

EPA Continues PFAS Regulatory Effort Through Community Engagement Tour

Trump-Era State Innovation Waivers: What’s in Store for 2019?

A ‘Goldilocks' Dodd-Frank Change

Crisis at the FTC? The Most Inexperienced Commission in Recent Times Prepares for Business

American Patients First: The Trump Administration's Blueprint to Lower Drug Prices

Notice & Comment: The War Over "Waters of the United States"

Mike Adelberg Explains Medicare Advantage Supplemental Benefits

FDA Officially Extends Deadline to Comply With Nutrition Facts Panel Regulation

What to Expect From the NLRB and Its Newly Confirmed Chairman

Building an Infrastructure Package: Energy & Environment Symposium Examines Issues Driving the Infrastructure Debate

Brexit and Trump: The Effect on Business Travel